Placeholder Banner

BIO Applauds House Passage of the Corporate Governance Reform and Transparency Act

December 21, 2017

Today, the Biotechnology Innovation Organization (BIO) applauds the House of Representatives for passing H.R. 4015, the Corporate Governance Reform and Transparency Act.  This bipartisan bill, sponsored by Reps. Sean Duffy (R-WI) and Gregory Meeks (D-NY), was approved by a 238-182 vote.

H.R. 4015 would provide for oversight by the Securities and Exchange Commission (SEC) of proxy advisory firms, ensuring that they operate within appropriate boundaries and are accountable to regulators and the public. 

The following statement may be attributed to BIO President and CEO Jim Greenwood:

“By enhancing transparency at proxy advisory firms, this legislation would improve the quality of information available to shareholders as they consider their views on public companies’ corporate governance policies. Proxy votes are the primary means of shareholder engagement with company management, and this bill would ensure that the proxy process is working well for both investors and issuers.

“By requiring proxy advisory firms to minimize conflicts of interest and enhance issuer dialogue, H.R. 4015 would improve the quality of the recommendations disseminated to shareholders and ensure that breakthrough innovation remains at the forefront of company decision-making.

“BIO thanks Representatives Duffy and Meeks for their leadership on this important issue.” 

Discover More
John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary leadership of Dr. Peter Marks, the FDA…
WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical supply chain. According to the findings, nearly 90…
WASHINGTON D.C. – Today, the Biotechnology Innovation Organization (BIO), in partnership with Kearney, a global management consulting firm, released a first-of-its-kind report that assesses the significant economic impact of the U.S. bioeconomy…